Investigations of temperament at three to seven years: the Children's Behavior Questionnaire.
M K Rothbart, S A Ahadi, K L Hershey...
https://pubmed.ncbi.nlm.nih.gov/11699677/Actively Recruiting
Led by University of California, Davis · Updated on 2026-06-04
50
Participants Needed
1
Research Sites
N/A
Total Duration
Problems with self-control, such as impulsivity, can lead to many challenges including substance abuse, academic difficulties, and health issues. For young children, developing self-control is vital for success in school and social life, yet few non-drug methods have proven effective. This research aims to test if a mobile app can help preschool-aged children with high impulsivity improve their self-control by gradually increasing the wait time for larger rewards through game play. The study involves a behavioral intervention called Shaping Delay Tolerance delivered via a tablet app called DelTA. Children will choose between a short immediate game or a longer game after a delay, with the app adjusting wait times to encourage longer delays for bigger rewards. Participants may take part in up to 25 training sessions lasting about 30 minutes each over a period of 3 to 6 weeks. The study includes an experimental group receiving immediate training and a wait-list control group that starts training after a 6-week wait. During the study, children will be assessed using various tools and questionnaires to measure changes in impulsivity and self-control, including tasks that test their ability to delay gratification. Parents and teachers will provide behavior ratings before and after training. Researchers will monitor progress over up to 6 weeks, focusing on changes in preference for delayed rewards. The total participation time varies depending on group assignment and training duration.
CONDITIONS
Shaping Tolerance for Delayed Rewards
S
Samantha Blair, PhD
S
Shannon Hoffman, DPT
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Davis
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Shaping delay tolerance (study intervention) | Wait‑list control | Standard behaviour training |
|---|---|---|---|
| What it is | An adaptive tablet‑based program that gradually increases pre‑reward delay over up to 25 roughly 30‑minute sessions across 3–6 weeks to train children to tolerate longer delays for larger rewards | Children remain on a wait‑list and do not receive the shaping delay tolerance training during the study period | Parent behaviour management training is guideline‑recommended first‑line behavioural therapy for impulsive preschool‑aged children |
| Role in trial | Investigational behavioural training intervention delivered via tablet | Active comparator as wait‑list control group | Represents current standard behavioural therapy outside the trial |
| What it is used for | To train delay tolerance and reduce impulsivity in young children | Serves as comparison to evaluate training effect over the study period | Used to help caregivers manage impulsivity through consistent behaviour strategies |
| How it is given or performed | Delivered via an adaptive app on a tablet, up to 25 sessions each lasting about 30 minutes over 3 to 6 weeks | Children do not receive intervention during the study period | Typically involves clinicians teaching structured behaviour strategies to caregivers to use at home and school |
| Evidence status | Efficacy is under investigation in this trial — no results yet | No efficacy data, serves as control comparator | Behaviour management training is supported by clinical guidelines and literature as effective first‑line intervention for preschoolers with ADHD |
| Important risks | Risks of tablet‑based training are not reported or established | No intervention during the study period, no direct risks from this arm | Behaviour management training is non‑pharmacologic; no specific risks described |
| Important limitations | Training is limited to short term (3–6 weeks) and effects beyond that timeframe are unknown | Wait‑list control may not control for attention or novelty effects of the tablet intervention | Effectiveness may depend on caregiver training quality, fidelity, and consistency across home and school |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 week
Participants complete initial assessments and questionnaires to establish baseline measures of impulsivity and behavior before beginning the intervention.
1 visit (in-person)
Duration - 3 to 6 weeks
Participants engage in up to 25 approximately 30-minute training sessions using a tablet-based application that gradually increases tolerance for delayed rewards through game play.
Multiple sessions, up to 25 sessions over 3 to 6 weeks
Duration - Up to 1 week
Participants complete behavioral assessments and questionnaires to evaluate changes in self-control and impulsivity after the intervention.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
M K Rothbart, S A Ahadi, K L Hershey...
https://pubmed.ncbi.nlm.nih.gov/11699677/J B Schweitzer, B Sulzer-Azaroff
https://pubmed.ncbi.nlm.nih.gov/7650090/J B Schweitzer, B Sulzer-Azaroff
https://pubmed.ncbi.nlm.nih.gov/3193054/Gregory P Hanley, Nicole A Heal, Jeffrey H Tiger...
https://pubmed.ncbi.nlm.nih.gov/17624068/Jeffrey R Gagne, Carol A Van Hulle, Nazan Aksan...
https://pubmed.ncbi.nlm.nih.gov/21480723/N M Laird, J H Ware
https://pubmed.ncbi.nlm.nih.gov/7168798/Samuel P Putnam, Mary K Rothbart
https://pubmed.ncbi.nlm.nih.gov/16856791/University of California, Davis
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor